Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Acute Pharyngitis Market from 2024 to 2025?
The market size for acute pharyngitis has seen considerable growth in the past few years. It is set to expand from $2.67 billion in 2024 to $2.90 billion in 2025, with a compound annual growth rate (CAGR) of 8.5%. The growth in the historical period is associated with factors such as the rising number of viral and bacterial infections, heightened awareness towards healthcare, advancements in diagnostic technology, an increase in pediatric cases, and heightened levels of environmental pollutants and allergens.
What Is the Projected Market Size of the Acute Pharyngitis Market?
In the coming years, the acute pharyngitis market is set to experience a major growth spurt, increasing to $3.98 billion in 2029 with a compound annual growth rate (CAGR) of 10.5%. This predicted growth is attributed to several factors such as the rising prevalence of influenza and streptococcal infections, a heightened focus on personalized medicine, the wide acceptance of rapid diagnostic tests, improvements in healthcare infrastructure, and increased healthcare access in emerging markets. Future trends likely to shape this market include a shift towards over-the-counter treatments, a growing use of combination therapies, the rise in telemedicine for pharyngitis diagnosis, increasing interest in natural and alternative remedies, and a growing preference for self and home-based treatments.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21082&type=smp
Who are the Major Competitors in the Acute Pharyngitis Market Outlook?
Major companies operating in the acute pharyngitis market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb, AstraZeneca plc, Novartis AG, Glaxo Smithkline Pharmaceuticals Ltd, F. Hoffmann-La Roche AG, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz Group AG, Bitop AG, Hikma Pharmaceuticals, Lupin Limited, Alkem Laboratories Ltd., MEDICE Arzneimittel Pütter GmbH & Co. KG, MCM Klosterfrau Vertriebsgesellschaft mbH
What Is Fueling Growth in the Acute Pharyngitis Market?
The acute pharyngitis market is predicted to grow due to an increase in influenza prevalence. Influenza, caused by influenza viruses, is transmitted through respiratory droplets that come from coughs, sneezes, or contact with germs on surfaces. The increasing prevalence of influenza can be attributed to factors like changes in seasons, insufficient vaccination rates, rising global travel, virus mutations, and vulnerable immunity in certain demographic groups. Treatment for acute pharyngitis provides relief for influenza patients by easing throat inflammation and painfulness, decreasing discomfort during swallowing, avoiding secondary bacterial infections, and aiding overall recovery. This treatment, along with antiviral drugs, fluid replenishing, and rest, boosts the body’s potential to combat the influenza virus more effectively. For example, the Centers for Disease Control and Prevention, a government agency based in the United States, revealed that by February 2025, the percentage of clinical lab tests indicating positive influenza results had ascended to 31.6%, a significant rise from 29.4% the preceding week and 18.6% at the beginning of the year. Therefore, the increasing prevalence of influenza is spearheading the growth of the acute pharyngitis market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21082&type=smp
Which Acute Pharyngitis Market Segments Are Growing the Fastest?
The acute pharyngitis market covered in this report is segmented –
1) By Treatment: Antibiotics, Antivirals, Over-the-Counter (OTC) Medications, Corticosteroids And Anti-inflammatory Drugs, Alternative Remedies
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
3) By End-User: Hospitals, Homecare, Speciality Centres, Other End Users
Subsegments:
1) By Antibiotics: Penicillins, Cephalosporins, Macrolides
2) By Antivirals: Neuraminidase Inhibitors, Nucleoside Analogs
3) By Over-the-Counter (OTC) Medications: Analgesics, Throat Lozenges, Cough Syrups
4) By Corticosteroids And Anti-inflammatory Drugs: Glucocorticoids, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
5) By Alternative Remedies: Herbal Teas, Honey-Based Solutions, Saltwater Gargles
Which Industry Trends Are Shaping the Future of the Acute Pharyngitis Market?
Leading firms in the acute pharyngitis market are putting their efforts into the creation of antibiotics to tackle bacterial infections with increased efficacy and curtail antibiotic resistance. Antibiotics play a key role in treating acute pharyngitis caused by bacterial infections such as streptococcus pyogenes as they eradicate the bacteria, diminish symptoms, and prevent further complications such as rheumatic fever. For example, in February 2022, Alembic Pharmaceuticals Limited, a pharmaceutical company based in India, secured approval for its Abbreviated New Drug Application (ANDA) for Clarithromycin tablets USP, 250 mg and 500 mg from the US-based government agency, the Food & Drug Administration (USFDA). This macrolide antibiotic is designed to address mild to moderate bacterial infections, incorporating pharyngitis or tonsillitis, community-acquired pneumonia, and chronic bronchitis. This approval signifies the essential role of potent antimicrobial treatments in handling acute pharyngitis and associated bacterial infections.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/acute-pharyngitis-global-market-report
Which Countries Are Leading the Acute Pharyngitis Market?
North America was the largest region in the acute pharyngitis market in 2024. The regions covered in the acute pharyngitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21082
This Report Delivers Insight On:
1. How big is the acute pharyngitis market, and how is it changing globally?
2. Who are the major companies in the acute pharyngitis market, and how are they performing?
3. What are the key opportunities and risks in the acute pharyngitis market right now?
4. Which products or customer segments are growing the most in the acute pharyngitis market?
5. What factors are helping or slowing down the growth of the acute pharyngitis market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model